Conn, Crystal S. http://orcid.org/0000-0003-3209-0445
Yang, Haojun http://orcid.org/0000-0003-2685-3899
Tom, Harrison J. http://orcid.org/0000-0001-9402-2371
Ikeda, Kenji
Oses-Prieto, Juan A. http://orcid.org/0000-0003-4759-2341
Vu, Hieu
Oguri, Yasuo
Nair, Supna http://orcid.org/0000-0001-6499-0099
Gill, Ryan M.
Kajimura, Shingo http://orcid.org/0000-0003-0672-5910
DeBerardinis, Ralph J. http://orcid.org/0000-0002-2705-7432
Burlingame, Alma L. http://orcid.org/0000-0002-8403-7307
Ruggero, Davide http://orcid.org/0000-0002-9444-5865
Article History
Received: 22 July 2020
Accepted: 19 January 2021
First Online: 18 February 2021
Competing interests
: R.J.D. is an advisor for Agios Pharmaceuticals. D.R. is a shareholder of eFFECTOR Therapeutics, Inc. and a member of its scientific advisory board. Other authors declare no competing interests.